Nan You

2.0k total citations
61 papers, 1.3k citations indexed

About

Nan You is a scholar working on Molecular Biology, Hepatology and Oncology. According to data from OpenAlex, Nan You has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 24 papers in Hepatology and 21 papers in Oncology. Recurrent topics in Nan You's work include Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Liver physiology and pathology (8 papers). Nan You is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Pancreatic and Hepatic Oncology Research (11 papers) and Liver physiology and pathology (8 papers). Nan You collaborates with scholars based in China, United States and Australia. Nan You's co-authors include Kaishan Tao, Kefeng Dou, Lu Zheng, Weihui Liu, Desheng Wang, Xiaobing Huang, Ru Ji, Liang Zhou, Xiaolei Li and Weiwei Wang and has published in prestigious journals such as Gastroenterology, PLoS ONE and Biomaterials.

In The Last Decade

Nan You

59 papers receiving 1.3k citations

Peers

Countries citing papers authored by Nan You

Since Specialization

Citations

This map shows the geographic impact of Nan You's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan You with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan You more than expected).

Fields of papers citing papers by Nan You

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan You. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan You. The network helps show where Nan You may publish in the future.

Co-authorship network of co-authors of Nan You

This figure shows the co-authorship network connecting the top 25 collaborators of Nan You. A scholar is included among the top collaborators of Nan You based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan You. Nan You is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Predicting the early therapeutic response to hepatic artery infusion chemotherapy in patients with unresectable HCC using a contrast-enhanced computed tomography-based habitat radiomics model: a multi-center retrospective study 2025 ·Cellular Oncology ·(unknown), (unknown), (unknown), (unknown), Jie Long, (unknown), Shunan Wang, Hao Wu, Nan You, (unknown), Liangzhi Wen	3
2	Machine learning-assisted tacrolimus dose optimization in childhood- onset systemic lupus erythematosus through population pharmacokinetic modeling 2025 ·Computers in Biology and Medicine ·Heng Liang, (unknown), Chuwei Liu, Arabella Wan, Nan You, Min Xiao, (unknown), (unknown), Guohui Wan	1
3	Sorafenib combined with transarterial chemoembolization compared with sorafenib alone in advanced hepatocellular carcinoma (SELECT): a multicenter, phase 3, randomized, controlled trial 2025 ·The Lancet Regional Health - Western Pacific ·Yan Zhao, Wei Bai, (unknown), Nan You, Lin Zheng, Lei Li, Jianbin Wu, Peng Zhang, Wukui Huang, Hui Zhang, Yongjin Zhang, (unknown), (unknown), (unknown), Daiming Fan, Yong Lv, Guohong Han	1
4	Intrahepatic Glisson Intrathecal Dissection via a Hepatic Parenchymal Transection-First Approach for Laparoscopic Anatomical Hemihepatectomy in Patients with Left/Right Glisson Pedicle Involvement 2024 ·Journal of Laparoendoscopic & Advanced Surgical Techniques ·Nan You, Ke Wu, Yongkun Li, (unknown)	1
5	Clinical and genetic characteristics in pancreatic cancer from Chinese patients revealed by whole exome sequencing 2023 ·Frontiers in Oncology ·(unknown), (unknown), Yichen Tang, Yuming Li, Xuehui Peng, Jing Li, (unknown), Nan You, Ling Li, Chuang Liu, Lu Zheng, Xiaobing Huang	6
6	977P Hepatic arterial infusion chemotherapy (HAIC) combined with Regorafenib and PD-1 inhibitors versus Regorafenib combined with PD-1 inhibitors for second-line treatment Hepatocellular carcinoma (HCC) 2023 ·Annals of Oncology ·Nan You, Xiaoniu Peng, J. Li, Lei Wang, Ke Wu, Zheng Lv, Di Li, Zhen Chen, Hongliang Zhang, (unknown), Yang Wang, Rui Liao, Qing Li, Ping Guo, Weili Wang	0
7	Galectin-7 Induction by EHMT2 Inhibition Enhances Immunity in Microsatellite Stability Colorectal Cancer 2023 ·Gastroenterology ·Lei Sun, (unknown), (unknown), Zhengyu Liu, Arabella Wan, Shijia Yan, Chuwei Liu, Heng Liang, (unknown), Nan You, (unknown), Yuan Deng, Xianzhang Bu, Dongshi Chen, Jun Huang, Xiaolei Zhang, Dong‐Ming Kuang, Guohui Wan	16
8	Bronchiectasis in Low-Dose CT Screening for Lung Cancer 2022 ·Radiology ·(unknown), (unknown), Yeqing Zhu, Nan You, Rowena Yip, David F. Yankelevitz, Claudia I. Henschke	10
9	Laparoscopic surgical management of hepatocellular carcinoma patients with diaphragmatic involvement 2022 ·Surgical Endoscopy ·Nan You, Zheng Wang, Ke Wu, Liang Wang, Jing Li, Lu Zheng	3
10	P-129 Camrelizumab combined with sorafenib versus sorafenib alone in patients with advanced hepatocellular carcinoma: A retrospective study 2020 ·Annals of Oncology ·(unknown), J. Li, Nan You, Ke Wu, Zhong Wang, (unknown), Lei Wang, Lu Zheng	2
11	Soluble Klotho Improves Hepatic Glucose and Lipid Homeostasis in Type 2 Diabetes 2020 ·Molecular Therapy — Methods & Clinical Development ·Huiying Gu, Wei Jiang, Nan You, Xiaobing Huang, Yuming Li, Xuehui Peng, Rui Dong, Zheng Wang, (unknown), Ke Wu, Jing Li, Lu Zheng	43
12	Arrestin domain containing 3 promotes Helicobacter pylori–associated gastritis by regulating protease-activated receptor 1 2020 ·JCI Insight ·Yugang Liu, Yong‐sheng Teng, (unknown), Ping Cheng, Chuan-jie Hao, Yi-pin Lv, (unknown), Shiming Yang, Weisan Chen, Yongliang Zhao, Nan You, Quanming Zou, Yuan Zhuang	15
13	Fecal microbiota transplantation prevents hepatic encephalopathy in rats with carbon tetrachloride-induced acute hepatic dysfunction 2017 ·World Journal of Gastroenterology ·Weiwei Wang, Yu Zhang, (unknown), Nan You, Lu Zheng, Jing Li	81
14	COMMD7 gene promotes HepG2 proliferation via extracellular regulated protein kinase/ mitogen-activated protein kinase signaling pathway 2015 ·Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi ·Yangyang Shang, Lu Zheng, Nan You, Xiaobing Huang, (unknown)	1
15	Proliferation inhibition and differentiation induction of hepatic cancer stem cells by knockdown of BC047440: A potential therapeutic target of stem cell treatment for hepatocellular carcinoma 2014 ·Oncology Reports ·Nan You, Lu Zheng, Weihui Liu, (unknown), Weiwei Wang, Jing Li	16
16	Overexpression of Bmi-1 contributes to the invasion and metastasis of hepatocellular carcinoma by increasing the expression of matrix metalloproteinase (MMP)-2, MMP-9 and vascular endothelial growth factor via the PTEN/PI3K/Akt pathway 2013 ·International Journal of Oncology ·Xiaolei Li, Zhao-Xu Yang, Wenjie Song, Liang Zhou, Qingjun Li, Kaishan Tao, Jingshi Zhou, Xing Wang, Zhigang Zheng, Nan You, Dou Ke-feng, Haimin Li	88
17	Notch is the key factor in the process of fetal liver stem/progenitor cells differentiation into hepatocytes 2012 ·Development Growth & Differentiation ·Tao Wang, Nan You, Kaishan Tao, Xing Wang, Ge Zhao, Ning Xia, Nanlin Li, Lijun Tang, Weihui Liu, Kefeng Dou	26
18	Efficient Enrichment of Hepatic Cancer Stem-Like Cells from a Primary Rat HCC Model via a Density Gradient Centrifugation-Centered Method 2012 ·PLoS ONE ·Weihui Liu, Xing Wang, Nan You, Kaishan Tao, Tao Wang, Lijun Tang, Dou Ke-feng	19
19	The differentiation of MSCs into functional hepatocyte-like cells in a liver biomatrix scaffold and their transplantation into liver-fibrotic mice 2012 ·Biomaterials ·Ru Ji, Ning Zhang, Nan You, Qiang Li, Weihui Liu, Nan Jiang, Jie Liu, Hongtao Zhang, Desheng Wang, Kaishan Tao, Kefeng Dou	105
20	MicroRNAs involved in neoplastic transformation of liver cancer stem cells 2010 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Niansong Qian, Kaishan Tao, Nan You, (unknown), Kefeng Dou	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact